Pontifax (Israel) III Limited Partnership

Pontifax (Israel) III Limited Partnership is a venture capital firm specializing in early-stage life sciences investments, focusing on innovative therapeutics and medical devices. The firm is based in Herzliya, Israel, and operates primarily in Israel and the United States. Pontifax manages assets totaling $1.2 billion and has invested in approximately 75 startups, aiming to address substantial unmet needs in the healthcare sector.

The firm's investment strategy encompasses various stages, including Seed, Series A, Series B, Growth Stage, and Bridge financing. Pontifax's portfolio spans multiple industries within the life sciences sector, such as biotechnology, medical devices, and pharmaceuticals. The firm is deeply involved in its portfolio management, taking a hands-on approach to nurture start-ups to maturity.

Pontifax was founded in 2004 and has established itself as a significant player in the venture capital landscape, particularly within the life sciences domain. The firm's commitment to transformative healthcare technologies is evident in its diverse and growing portfolio, reflecting its dedication to advancing medical innovation and improving patient outcomes.